产品名称 | NebuSelect™ Recombinant Human LY6G6D, hFc-tag |
---|---|
目录号 | NBL-241430 |
别名 | LY6G6D |
外观 | see COA |
分子量 | |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | O95868 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-241430-100ug | 100ug | Inquire | Inquire | |
NBL-241430-1mg | 1mg | Inquire | Inquire | |
NBL-241430-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human LY6G6D, hFc-tag
Catalog#:
NBL-241430
Description:
NebuSelect™ Recombinant Human LY6G6D, hFc-tag(Cat#NBL-241430) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Asn20-Ser104.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 35.87 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on Bis-Tris PAGE result.
Target Name:
LY6G6D
Target Information:
LY6G6D is a selectively expressed colorectal cancer antigen that can be used for targeting a therapeutic T-cell response by a T-cell engager.LY6G6D was identified as a selectively expressed CRC antigen that can be utilized to potently re-direct and activate cytotoxic T-cells to lyse LY6G6D expressing CRC using a TcE. This effect can be spread to target negative neighboring tumor cells, potentially leading to improved therapeutic efficacy.
Amino Acid Sequence:
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.